Krüppel样因子17,一种新型肿瘤抑制因子:其低表达与癌症转移有关。
Krüppel-like factor 17, a novel tumor suppressor: its low expression is involved in cancer metastasis.
作者信息
Zhou Shan, Tang Xiaowei, Tang Faqing
机构信息
Medical Research Center and Clinical Laboratory, Zhuhai People's Hospital and Zhuhai Hospital of Jinan University, 79 Kangning Road, Zhuhai, 519000, Guangdong, China.
Metallurgical Science and Engineering, Central South University, 21# Lushan South Road, Changsha, 410083, China.
出版信息
Tumour Biol. 2016 Feb;37(2):1505-13. doi: 10.1007/s13277-015-4588-3. Epub 2015 Dec 12.
Krüppel-like factor (KLF) family is highly conserved zinc finger transcription factors that regulate cell proliferation, differentiation, apoptosis, and migration. KLF17 is a member of the KLF family. Recent studies have demonstrated that KLF17 low expression and inactivation are caused by microRNA, gene mutation, and loss of heterozygosity in human tumors, which participates in tumor progression. KLF17 low expression increases cancer metastatic viability; its mechanism is that low KLF17 mediates epithelial-mesenchymal transition (EMT) through regulating EMT-related genes expression; the reduced-KLF17 also increases cancer metastasis though upregulating inhibitor of DNA binding 1 (ID1). Additionally, mutant p53 proteins are capable of developing a complex with KLF17, which mediate the depletion of KLF17 inhibiting EMT gene transcription and increases cancer metastasis. KLF17 downregulation also mediates the activation of TGF-β pathway.
Krüppel样因子(KLF)家族是高度保守的锌指转录因子,可调节细胞增殖、分化、凋亡和迁移。KLF17是KLF家族的成员。最近的研究表明,KLF17的低表达和失活是由人类肿瘤中的微小RNA、基因突变和杂合性缺失引起的,其参与肿瘤进展。KLF17低表达增加癌症转移生存能力;其机制是低KLF17通过调节EMT相关基因表达介导上皮-间质转化(EMT);KLF17减少还通过上调DNA结合抑制因子1(ID1)增加癌症转移。此外,突变型p53蛋白能够与KLF17形成复合物,介导KLF17的消耗,抑制EMT基因转录并增加癌症转移。KLF17下调还介导TGF-β途径的激活。
相似文献
J Int Med Res. 2021-11
Biochem Biophys Res Commun. 2012-1-3
引用本文的文献
Anticancer Agents Med Chem. 2025
Front Oncol. 2023-1-25
Development. 2021-11-15
Proc Natl Acad Sci U S A. 2020-7-27
Am J Cancer Res. 2020-2-1
本文引用的文献
Biochem J. 2015-8-1
Tumour Biol. 2015-2
Biochem Pharmacol. 2015-2-1
Curr Top Dev Biol. 2014
Curr Opin Cell Biol. 2014-12